Stock Events

Stock Events

Matinas BioPharma (MTNB) Q3 2024 Earnings

14AugConfirmed

Q2 2023

Q3 2023

Q2 2024

Q3 2024

-1.25

-0.84

-0.44

-0.03

Details

Expected EPS

-1.25

Actual EPS

-1

Surprise EPS

0.25

Surprise Percent

+20%

Description

Matinas BioPharma (MTNB) has reported earnings of -1 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.